Sports betting and cannabis stocks are proving to be safe bets in 2021. As the effects of the pandemic are wearing off, Investor Telegraph presents a 2+2 opportunity for investing
GAN Limited (NASDAQ: GAN)
The stock jumped nearly 25% in December, as the bullishness toward online gambling stocks started gaining momentum. But for GAN the biggest news was a public offering of 7.2 million shares for $15.50 per share during the pandemic times. The offering was announced mid-month and raised about $111 million for the company before fees.
This was a big offering for a company like GAN, but it could be the right move long term. Its value looks attractive at its present price of $25
Scientific Games Corporation’s (NASDAQ: SGMS)
The company develops technology-based products and services, and related content for the gaming, lottery, social and digital gaming industries in the United States and internationally.
The company is bordering on breakeven, as it is expected to give a profit of US$12m in 2021. In recent trading, shares of Scientific Games Corp crossed above the average analyst 12-month target price of $45.00, changing hands for $45.51share.
The stock has returned a staggering 763% to shareholders over the last five years and looks like an investment at the present price of $47.
GrowGeneration (NASDAQ: GRWG)
GRGW is known for its retail of hydroponic and organic specialty gardening products. . In fact, it is currently the largest player in the U.S. with 40 retail and distribution centers.
The stock had a great year in 2020 with its shares grow from about $4 last January to $40 at the end of December — a roughly 900% gain.GrowGeneration also entered the pandemic economy from a place of remarkable strength, having reported 176% revenue growth in 2019.
The company has reported consistent, record revenue increases throughout the pandemic while continuing to expand its retail presence in new key markets. At a price of $ 45, it has all the looks of a potential winner.
OrganiGram Holdings (NASDAQ:OGI)
Based in Atlantic Canada, OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as alternative medicine.
OGI stock gained momentum in the first week of Feb and has since been very actively traded. Medicinal cannabis is now legal in 30 states in America with a projected market of $37.9 billion by 2024 according to research.
The stock looks undervalued at $ 3.00 presently.
Dow Clears 34K, Nasdaq Tops 14K as ‘apps’ is the new flavor of Wall St.
Wall St. : Stocks mixed as digital assets strive to make an impact
Nasdaq up, Dow slips amidst J&J vaccine row as SPAC is back in news
NYSE launches ‘First Trade’ NFTs of Spotify, Snowflake; aims at digi-asset creation
Stocks future down as Powell’s re-assurance falls flat ; U.S. faces vaccination hiccups
SEC is scrutinizing SPAC projections, seeks clearer disclosures
Markets show promise as Biden asked Congress for a $400 annual increase in maximum Pell grants for college students
Dow Jones up, Nasdaq rallies as Powell stresses on a more robust recovery
Stock futures rise as Cruise Line stocks trade higher
Stock futures higher after major averages close lower, S&P 500 down from record level
Business7 months ago
Airlines from US are expecting to get another aid package for $25 billion to keep business from falling
Business5 months ago
Delta hints at possible purchase of Boeing’s 737 MAX : Financial Times
Business3 months ago
5 ‘value investing’ Sin Stocks of 2021- An Investor Telegraph Exclusive .
Business5 months ago
Chinese jet ready to challenge Airbus and Boeing, C 919 in final testing stage
News6 months ago
Cuban economy has lost $144 billion due to US trade restriction
Business3 months ago
5 Chinese stocks likely to give a 40% plus return in 2021 : An Investor Telegraph Exclusive
Business4 months ago
NASDAQ posts record high as U.S. stocks gain momentum, S&P 500 closes lower
Markets9 months ago
Snap, Datadog, Crowdstrike and other stocks bounced back in the ‘Buy’ rating